IGC BIO INC has a total of 16 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2017. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, computer technology and measurement are LI MEIFENG, YICHANG CHANGJIANG PHARMACEUTICAL CO LTD and MIEDZYNARODOWY INST BIOLOG MOLEKULARNEJ I KOMORKOWEJ.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 8 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Computer technology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks | |
#6 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Bioinformatics | |
#4 | Analysing materials | |
#5 | Computational chemistry | |
#6 | Combinatorial chemistry | |
#7 | Enzymes | |
#8 | Medical preparations | |
#9 | Electric digital data processing | |
#10 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Zimmerman Lior | 15 |
#2 | Baran Dror | 13 |
#3 | Schindler Daniel | 1 |
Publication | Filing date | Title |
---|---|---|
US2020126640A1 | Computational affinity maturation of antibody libraries using sequence enumeration | |
US2019367614A1 | Anti-pd-1 scfvs | |
US2020291366A1 | Pross optimized enzymes | |
US2020207844A1 | Anti-vegf antibody | |
US2020255813A1 | Pross optimized enzymes | |
WO2018165046A1 | A computational pipeline for antibody modeling and design | |
WO2018129425A1 | System and method for generating antibody libraries | |
US2018057961A1 | Computational methods for designing polypeptide libraries | |
WO2017214211A1 | Methods for identifying a high affinity antibody | |
WO2017210149A1 | Compositions and methods for generating an antibody library | |
WO2017210148A1 | Compositions and methods for self-recombination plasmid transformation |